RE:RE:Another tweet this morningThe nerve of you to acuse someone else on this board of pumping this stock and conning the masses. Just a couple weeks ago you were in full pump mode and trashing everyone who had anything critical to say. How many double digit Price targets have you put out for this stock in the past month you clown. Lets look at some of your pump, pump, pump greatest hits.
Dec 1
I added more shares yesterday and again today as I am fairly confident we will see KNR's share price in the double digits by the end of this month
Dec 3
Funny how this scum bag continues to post disparaging comments about KNR's progress. Keep trying moron your losing the battle.
Dec 18
No Brainer. Thanks for the cheap shares this morning. Low volume day so glad to pick up shares from the weak hands. We know sales are coming. Do you really think Paul is pushing his team as hard as he has to move this BioCloud device forward if he does not see demand at meaningful levels? Remember my conservative share price based on annual projected BioCloud sales of only 6,000 units was $9. Have patience folks. There is a good opportunity here. Do your DD. LTD1
Dec 30
Glad to have the opportunity to add shares today. One more day of 2020 trading after today and then we are into January. I am banking on Paul releasing news early in the New Year. With the recent pull back news does not have to be too significant to get a nice pop on the share price. Patience will pay off on this stock.
Jan 10
That is one additional thing I like about Paul and his team at Kontrol. All significant news stays inside the walls and no information leaks appear before news breaks. With UAE BioCloud trial news coming as early as Monday, KNR's share price is trading at levels that price in very little BioCloud news. We could get a halt any day now and if the UAE news is great KNR's share price would double or triple in a matter of minutes. The low float of tradable shares is the reason we could see such a significant share price news on very positive news. The upcoming news report on BioCloud could be another trigger for a nice share price jump along with any mention of BioCloud in the recent very significant funding announced for Ontario school HVAC upgrades. Any of these three triggers could come this week or not. Roll the dice folks. A betting man would have to say the potential upside on KNR's stock price should out weigh any downside risk. It all depends on BioCloud success. The question one should ask themselves is .... do you really think Paul would go through all the work pursuing TSX and Nasdaq listings if he thought BioClouds chance of success was marginal? I don't think so.
Talk about supercharged hype, and to come back a few weeks later and trash people for doing the same thing you did for months on end is shameful. Either you have mental issues or you are not a honest person at all.